Menu Search
Equities

Vitrolife AB

VTFN:DEU

Vitrolife AB

Actions
  • Price (EUR)20.22
  • Today's Change-0.42 / -2.03%
  • Shares traded1.59k
  • 1 Year change+50.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Vitrolife AB had net income fall from a gain of 394.00m to a loss of 3.85bn despite a 8.60% increase in revenues from 3.23bn to 3.51bn.
Gross margin58.16%
Net profit margin-107.03%
Operating margin-100.06%
Return on assets-19.99%
Return on equity-24.90%
Return on investment-20.71%
More ▼

Cash flow in SEKView more

In 2023, Vitrolife AB increased its cash reserves by 48.96%, or 283.00m. The company earned 757.00m from its operations for a Cash Flow Margin of 21.55%. In addition the company used 124.00m on investing activities and also paid 300.00m in financing cash flows.
Cash flow per share-24.84
Price/Cash flow per share--
Book value per share97.03
Tangible book value per share-7.67
More ▼

Balance sheet in SEKView more

Vitrolife AB has a Debt to Total Capital ratio of 13.50%, a higher figure than the previous year's 11.54%.
Current ratio2.91
Quick ratio2.36
Total debt/total equity0.156
Total debt/total capital0.135
More ▼

Growth rates in SEK

SmartText is unavailable
Div yield(5 year avg)0.25%
Div growth rate (5 year)3.30%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-1,046.56
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.